Theravance Biopharma Inc (TBPH) support and resistance · P/E 7.5, rev $38.4M
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
This page maps Theravance Biopharma Inc (TBPH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TBPH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TBPH quote page for the session range and the stock page for the full model.
Not investment advice.